Literature DB >> 19827683

[Metabolic abnormalities as a basis for age-dependent diseases and aging? State of the art].

E V Tereshina.   

Abstract

Metabolic syndrome (MS) is a number of certain criteria reflecting abnormalities in lipid and glucose metabolism. These abnormalities are considered to be a reason for atherosclerosis, cardiovascular diseases (CVD) and diabetes mellitus type 2. The prevalence of CVD among those with diabetes is 3-5 folds higher than without diabetes. MS demonstrates ethnic and gender variants, its frequency depends on the lifestyle and age. Attention to MS has been attracted in the last decades induced by the obesity epidemic in US. The adipose tissue and high triglyceride blood levels have been regarded as hallmark of MS. It has appeared that metabolic ways of cholesterol, fat and glucose were tightly connected and united in a system of energy expenditure and reproduction. The high prevalence of MS, heart attacks and diabetes in the elderly population makes the evidence of age to be an independent risk factor of the development of metabolic abnormalities. But this problem is still out of the field of interest in gerontology. There exist a number of unsolved questions concerning the function of visceral adipose tissue, the role of free fatty acids in the insulin resistance, mechanisms of inflammation in the old age and so on that can be an object of gerontology. So, a program of advanced researches in this field is discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19827683

Source DB:  PubMed          Journal:  Adv Gerontol        ISSN: 1561-9125


  6 in total

1.  Aging, metabolic syndrome and the heart.

Authors:  Guarner Veronica; Rubio-Ruiz Maria Esther
Journal:  Aging Dis       Date:  2012-03-13       Impact factor: 6.745

2.  Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?

Authors:  Eduardo Mansilla; Vanina Díaz Aquino; Daniel Zambón; Gustavo Horacio Marin; Karina Mártire; Gustavo Roque; Thomas Ichim; Neil H Riordan; Amit Patel; Flavio Sturla; Gustavo Larsen; Rubén Spretz; Luis Núñez; Carlos Soratti; Ricardo Ibar; Michiel van Leeuwen; José María Tau; Hugo Drago; Alberto Maceira
Journal:  Stem Cells Int       Date:  2011-06-13       Impact factor: 5.443

3.  The effects of graded levels of calorie restriction: XI. Evaluation of the main hypotheses underpinning the life extension effects of CR using the hepatic transcriptome.

Authors:  Davina Derous; Sharon E Mitchell; Lu Wang; Cara L Green; Yingchun Wang; Luonan Chen; Jing-Dong J Han; Daniel E L Promislow; David Lusseau; Alex Douglas; John R Speakman
Journal:  Aging (Albany NY)       Date:  2017-07-31       Impact factor: 5.682

4.  Altered FoxO1 and PPARγ interaction in age-related ER stress-induced hepatic steatosis.

Authors:  Dae Hyun Kim; Sugyeong Ha; Yeon Ja Choi; H Henry Dong; Byung Pal Yu; Hae Young Chung
Journal:  Aging (Albany NY)       Date:  2019-06-25       Impact factor: 5.682

5.  Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal Ranges.

Authors:  Aleksandra Wyczalkowska-Tomasik; Bozena Czarkowska-Paczek; Magdalena Zielenkiewicz; Leszek Paczek
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-08-18       Impact factor: 4.291

6.  Mechanism of Lipid Accumulation through PAR2 Signaling in Diabetic Male Mice.

Authors:  Dae Hyun Kim; Ye Ra Kim; EunJin Bang; Sugyeong Ha; Sang Gyun Noh; Byeong Moo Kim; Seong Ho Jeong; Hee Jin Jung; Ji Young Lee; Hae Young Chung
Journal:  Endocrinol Metab (Seoul)       Date:  2021-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.